Citation: Jiaojiao Yang, Shaokun Yang, Wei Cheng, Jie Wu, Haijing Qu, Han Chen, Zhiran Duan, Yuqing Pan, Ning Wang, Chao Wang, Jian Gao, Bai Xiang, Xiangdong Xue. Self-assembled cyclodextrin-porphyrin nanoplatform for synergistic chemo-phototherapy and targeted delivery of camptothecin against breast cancer[J]. Chinese Chemical Letters, ;2026, 37(4): 111901. doi: 10.1016/j.cclet.2025.111901 shu

Self-assembled cyclodextrin-porphyrin nanoplatform for synergistic chemo-phototherapy and targeted delivery of camptothecin against breast cancer

Jiaojiao Yang ^{a, b, 1} ,
Shaokun Yang ^{a, b, 1} ,
Wei Cheng ^c ,
Jie Wu ^c ,
Haijing Qu ^c ,
Han Chen ^c ,
Zhiran Duan ^c ,
Yuqing Pan ^c ,
Ning Wang ^c ,
Chao Wang ^c ,
Jian Gao ^a ,
Bai Xiang ^{a, b, *,} ,
Xiangdong Xue ^{c, *,}

a.
Hebei Key Laboratory of Innovative Drug Research and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China
b.
National Key Laboratory of New Pharmaceutical Preparations and Excipients, Shijiazhuang 050017, China
c.
Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai 200240, China

baixiang@hebmu.edu.cn

xuexd@sjtu.edu.cn

Received Date: 3 July 2025
Revised Date: 23 September 2025
Accepted Date: 25 September 2025
Available Online: 25 September 2025

Figures(5)

The management of breast cancer remains clinically intractable, driven by its highly invasive behavior and limited susceptibility to conventional treatments. In this study, we engineered an innovative cyclodextrin-porphyrin co-assembled nanoplatform (CT NPs) to enable multimodal breast cancer therapy. By successfully encapsulating camptothecin (CPT) within this nanocarrier, the system (CTC NPs) achieved synergistic chemo-phototherapeutic efficacy through dual-modality action. The highly biocompatible cyclodextrin carrier significantly improved the physicochemical characteristics of CPT. In vivo studies revealed that CTC NPs effectively evaded clearance by the reticuloendothelial system, overcame the defect of premature drug leakage, and exhibited superior tumor targeting and infiltration capabilities. Under near-infrared (NIR) laser irradiation, CTC NPs can simultaneously induce localized hyperthermia and produce reactive oxygen species (ROS), thereby achieving efficient tumor ablation. In 4T1 tumor-bearing mice, CTC NPs exhibited targeted, safe, and highly potent anti-tumor efficacy, significantly suppressing both primary tumor progression (tumor suppression rate > 95%) and metastatic dissemination. In summary, this integrated nanoplatform establishes a novel theranostic paradigm for synergistic chemo-phototherapy against triple-negative breast cancer (TNBC), achieving precise tumor ablation through NIR-triggered drug release and real-time imaging guidance.
- Breast cancer,
- Drug delivery,
- Camptothecin,
- PDT,
- PTT
1. [1]
  N. Harbeck, M. Gnant, Lancet 389 (2017) 1134–1150. doi: 10.1016/S0140-6736(16)31891-8
2. [2]
  M. Arnold, E. Morgan, H. Rumgay, et al., Breast 66 (2022) 15–23. doi: 10.1016/j.breast.2022.08.010
3. [3]
  J. Wang, Y. Fan, S. Xu, et al., Chin. Chem. Lett. 37 (2026) 111607. doi: 10.1016/j.cclet.2025.111607
4. [4]
  C. Yang, H. Liu, X. Feng, et al., Int. J. Surg. 110 (2024) 4976–4992. doi: 10.1097/js9.0000000000001586
5. [5]
  Y. Liang, H. Zhang, X. Song, Q. Yang, Semin. Cancer Biol. 60 (2020) 14–27. doi: 10.3390/polym13010014
6. [6]
  G. Curigliano, H.J. Burstein, E.P. Winer, et al., Ann. Oncol. 28 (2017) 1700–1712. doi: 10.1093/annonc/mdx308
7. [7]
  S. Marsh, G. Liu, Adv. Drug Deliv. Rev. 61 (2009) 381–387. doi: 10.1016/j.addr.2008.10.003
8. [8]
  F. Poggio, M. Bruzzone, M. Ceppi, et al., J. Clin. Oncol. 36 (2018) 1497–1508.
9. [9]
  N. Khaiwa, N.R. Maarouf, M.H. Darwish, et al., Eur. J. Med. Chem. 223 (2021) 113639. doi: 10.1016/j.ejmech.2021.113639
10. [10]
  A. Thomas, Y. Pommier, Clin. Cancer Res. 25 (2019) 6581–6589. doi: 10.1158/1078-0432.ccr-19-1089
11. [11]
  M.D. Wang, D.Y. Hou, G.T. Lv, et al., Biomaterials 278 (2021) 121139. doi: 10.1016/j.biomaterials.2021.121139
12. [12]
  Y. Wang, Q. Tang, R. Wu, et al., ACS Nano 17 (2023) 3557–3573. doi: 10.1021/acsnano.2c09948
13. [13]
  M. Landgraf, C.A. Lahr, I. Kaur, et al., Biomaterials 240 (2020) 119791. doi: 10.1016/j.biomaterials.2020.119791
14. [14]
  M. Sun, H. Jiang, T. Liu, et al., Acta Pharm. Sin. B 12 (2022) 952–966. doi: 10.1016/j.apsb.2021.08.008
15. [15]
  M. Su, Y. Chen, L. Jia, Z. Zhang, Int. J. Nanomed. 17 (2022) 6687–6705. doi: 10.2147/ijn.s359300
16. [16]
  D.J. Jang, C. Moon, E. Oh, Biomed. Pharmacother. 80 (2016) 162–172. doi: 10.1016/j.biopha.2016.03.018
17. [17]
  M. Shahriari, S.M. Taghdisi, K. Abnous, M. Ramezani, M. Alibolandi, J. Control. Rel. 335 (2021) 369–388. doi: 10.1016/j.jconrel.2021.05.039
18. [18]
  R. Lagoa, J. Silva, J.R. Rodrigues, A. Bishayee, Biotechnol. Adv. 38 (2020) 107382. doi: 10.1016/j.biotechadv.2019.04.004
19. [19]
  K. Yang, Z. Yang, G. Yu, et al., Adv. Mater. 34 (2022) e2107434. doi: 10.1002/adma.202107434
20. [20]
  X. Dong, R.K. Brahma, C. Fang, S.Q. Yao, Chem. Sci. 13 (2022) 4239–4269. doi: 10.1039/d2sc01003h
21. [21]
  X. Xue, H. Qu, Y. Li, Exploration 2 (2022) 20210134. doi: 10.1002/EXP.20210134
22. [22]
  H. Li, M. Zhang, J. He, et al., Chin. Chem. Lett. 36 (2025) 110615. doi: 10.1016/j.cclet.2024.110615
23. [23]
  F. Tong, Y. Zhou, Y. Xu, et al., Exploration 3 (2023) 20210111. doi: 10.1002/EXP.20210111
24. [24]
  M.E. Davis, M.E. Brewster, Nat. Rev. Drug Discov. 3 (2004) 1023–1035. doi: 10.1038/nrd1576
25. [25]
  Y. Zhang, T. Sun, C. Jiang, Acta Pharm. Sin. B 8 (2018) 34–50. doi: 10.3390/w11010034
26. [26]
  D. Sun, Y. Zou, L. Song, et al., Acta Pharm. Sin. B 12 (2022) 378–393. doi: 10.1016/j.apsb.2021.06.005
27. [27]
  P. Lv, C. Zhou, Y. Zhao, X. Liao, B. Yang, Carbohydr. Polym. 168 (2017) 103–111. doi: 10.1016/j.carbpol.2017.02.036
28. [28]
  J. Li, X.J. Loh, Adv. Drug Deliv. Rev. 60 (2008) 1000–1017. doi: 10.1016/j.addr.2008.02.011
29. [29]
  S. Khammar, N. Bahramifar, H. Younesi, J. Hazard. Mater. 394 (2020) 122422. doi: 10.1016/j.jhazmat.2020.122422
30. [30]
  L. Chen, Y. Lin, Z. Zhang, et al., J. Nanobiotechn. 19 (2021) 329. doi: 10.1186/s12951-021-01064-3
31. [31]
  P. Nonsuwan, P.P. Phiboonchaiyanan, N. Hirun, P. Kraisit, Carbohydr. Polym. 321 (2023) 121294. doi: 10.1016/j.carbpol.2023.121294
32. [32]
  M. Zhou, Y. Long, Y. Zhi, X. Xu, Chin. Chem. Lett. 29 (2018) 1399–1403. doi: 10.1016/j.cclet.2017.10.039
33. [33]
  A.G. Denkova, R.M. de Kruijff, P. Serra-Crespo, Adv. Healthc. Mater. 7 (2018) e1701211. doi: 10.1002/adhm.201701211
34. [34]
  X. Li, J.F. Lovell, J. Yoon, X. Chen, Nat. Rev. Clin. Oncol. 17 (2020) 657–674. doi: 10.1038/s41571-020-0410-2
35. [35]
  W. Cheng, H.J. Qu, J.J. Yang, et al., ACS Nano 19 (2025) 557–579. doi: 10.1021/acsnano.4c11006
36. [36]
  W. Sun, X. Zhao, J. Fan, J. Du, X. Peng, Small 15 (2019) e1804927. doi: 10.1002/smll.201804927
37. [37]
  L. Zhao, X. Zhang, X. Wang, et al., J. Nanobiotechn. 19 (2021) 335. doi: 10.1109/icid54526.2021.00073
38. [38]
  H. Hu, W. Feng, X. Qian, et al., Adv. Mater. 33 (12) (2021) e2005062. doi: 10.1002/adma.202005062
39. [39]
  W. Cheng, Z. Duan, H. Chen, et al., Acta Biomater. 193 (2025) 392–405. doi: 10.1016/j.actbio.2025.01.016
40. [40]
  H. Chen, H. Qu, B. Lu, et al., Nanoscale 16 (2024) 14734–14747. doi: 10.1039/d4nr02101k
41. [41]
  H. Qu, L. Li, H. Chen, et al., J. Control. Rel. 363 (2023) 361–375. doi: 10.1016/j.jconrel.2023.09.042
42. [42]
  Z. Li, X. Wu, L. Li, et al., Chin. Chem. Lett. 37 (2026) 111501. doi: 10.1016/j.cclet.2025.111501
43. [43]
  S. Hu, W. Zhang, Z. Ni, et al., Chin. Chem. Lett. (2025), doi:10.1016/j.cclet.2025. 111523. doi: 10.1016/j.cclet.2025.111523
44. [44]
  X. Xue, A. Lindstrom, Y. Li, Bioconjug Chem. 30 (2019) 1585–1603. doi: 10.1021/acs.bioconjchem.9b00231
45. [45]
  M.S.H. Lim, T. Ohtsuki, F. Takenaka, et al., Life 11 (2021) 158. doi: 10.3390/life11020158
46. [46]
  D. Wu, Z. Zhang, X. Li, et al., Acta Biomater. 168 (2023) 565–579. doi: 10.1016/j.actbio.2023.07.022
47. [47]
  Y. Pan, H. Qu, H. Chen, et al., Acta Biomater. 193 (2025) 377–391. doi: 10.3390/photonics12040377
48. [48]
  K. Yang, S. Qi, X. Yu, et al., Angew. Chem. Int. Ed. 61 (2022) e202203786. doi: 10.1002/anie.202203786
49. [49]
  V.R. Pattabiraman, J.W. Bode, Nature 480 (2011) 471–479. doi: 10.1038/nature10702
50. [50]
  M. Feng, H. Zhang, N. Maulide, Angew. Chem. Int. Ed. 134 (2022) e202212213. doi: 10.1002/ange.202212213
51. [51]
  H. Bai, J. Wang, C.U. Phan, et al., Nat. Commun. 12 (2021) 759. doi: 10.1038/s41467-021-21071-0
52. [52]
  L. Cao, H. Tian, M. Fang, et al., Biomaterials 290 (2022) 121856. doi: 10.1016/j.biomaterials.2022.121856
53. [53]
  X. Ge, Y. Hao, H. Li, et al., J. Nanobiotechn. 20 (2022) 369. doi: 10.1186/s12951-022-01577-5
54. [54]
  A. Ocana, C. Nieto-Jimenez, A. Pandiella, A.J. Templeton, Mol. Cancer 16 (2017) 137. doi: 10.1186/s12943-017-0707-7
1. [1]
  Haijiao Li , Mingzu Zhang , Jinlin He , Jian Liu , Xingwei Sun , Peihong Ni . Synthesis of curcumin polyprodrug via click chemistry and construction of dual-drug-loaded nano platform for highly efficient tumor treatment. Chinese Chemical Letters, 2025, 36(8): 110615-. doi: 10.1016/j.cclet.2024.110615
2. [2]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
3. [3]
  Xincheng Sun , Yuxin Wang , Changkang Li , Ridao Chen , Kebo Xie , Jimei Liu , Songyang Sui , Yaotian Han , Dawei Chen , Jungui Dai . Functional characterization of a glycoside hydrolase in the biosynthesis of camptothecin from Camptotheca acuminata. Chinese Chemical Letters, 2025, 36(12): 110895-. doi: 10.1016/j.cclet.2025.110895
4. [4]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
5. [5]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
6. [6]
  Lijuan Liu , Zhihao Zhao , Feiwan Zou , Wukun Liu , Yunlong Lu . Advances in combination therapy for the treatment of estrogen receptor positive breast cancer. Chinese Chemical Letters, 2025, 36(10): 111451-. doi: 10.1016/j.cclet.2025.111451
7. [7]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
8. [8]
  Xinyue Han , Yunhan Yang , Jiayin Lu , Yuxiang Lin , Dongxue Zhang , Ling Lin , Liang Qiao . Efficient serum lipids profiling by TiO₂-dopamin-assisted MALDI-TOF MS for breast cancer detection. Chinese Chemical Letters, 2025, 36(5): 110183-. doi: 10.1016/j.cclet.2024.110183
9. [9]
  Lulu He , Le Wang , Zhen He , Yiqian Yang , Cheng Heng Pang , Aiguo Wu , Bencan Tang , Juan Li . An imine-linked covalent organic framework with intrinsic photo-induced mitochondrial regulation for breast cancer therapy. Chinese Chemical Letters, 2025, 36(9): 110717-. doi: 10.1016/j.cclet.2024.110717
10. [10]
  Jia Wang , Yunxiu Fan , Shilin Xu , Zhouxue Wu , Tian Hu , Yun Lu , Yue Li , Kang Xiong , Hongjun Deng , Jingrong Huang , Bo Yang , Shaozhi Fu . Self-propelled biomotors co-deliver doxorubicin liposomes and aPD-1 antibody to fight breast cancer. Chinese Chemical Letters, 2026, 37(2): 111607-. doi: 10.1016/j.cclet.2025.111607
11. [11]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
12. [12]
  Yan Yu , Cailing Gan , Kun Shi , Zhongwu Bei , Yang Yu , Meng Pan , Hanzhi Deng , Zhiyong Qian . Recent advances in drug delivery systems for pulmonary fibrosis therapy. Chinese Chemical Letters, 2026, 37(1): 111596-. doi: 10.1016/j.cclet.2025.111596
13. [13]
  Guanlong Li , Zhuoyan Li , Yan Sun , Tiange Bu , Shaochuan Chen , Leixin Yang , Zhi Li , Wenyue Mao , Yanpeng Jia . Advances in CNS drug delivery strategies to cross the blood-brain barrier. Chinese Chemical Letters, 2026, 37(1): 111524-. doi: 10.1016/j.cclet.2025.111524
14. [14]
  Menglin Zhang , Fanpeng Ran , Yun Zhang , Xiaoli Zhang , Zhigang Xu , Xiaoxiao Shi . Cyclodextrin-based nanotherapeutics: A promising strategy for enhanced cancer therapy. Chinese Chemical Letters, 2026, 37(1): 111232-. doi: 10.1016/j.cclet.2025.111232
15. [15]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
16. [16]
  Xingqun Pu , Rongrong Liu , Yuting Xie , Chenjing Yang , Jingyi Chen , Baoling Guo , Chun-Xia Zhao , Peng Zhao , Jian Ruan , Fangfu Ye , David A Weitz , Dong Chen . One-step preparation of biocompatible amphiphilic dimer nanoparticles with tunable particle morphology and surface property for interface stabilization and drug delivery. Chinese Chemical Letters, 2025, 36(3): 109820-. doi: 10.1016/j.cclet.2024.109820
17. [17]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
18. [18]
  Lulu Cao , Yikun Li , Dongxiang Zhang , Shuai Yue , Rong Shang , Xin-Dong Jiang , Jianjun Du . Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy. Chinese Chemical Letters, 2024, 35(12): 109735-. doi: 10.1016/j.cclet.2024.109735
19. [19]
  Mengjie Gao , Zhiqiang Cui , Yue Shen , Yikun Li , Dongxiang Zhang , Xiaoyan Gao , Yaguang Sun , Xin-Dong Jiang , Jianjun Du , Xiaohong Sun . NIR-II emissive aza-BODIPY-based nanoparticles for triggering glioblastoma apoptosis in brain. Chinese Chemical Letters, 2025, 36(5): 110098-. doi: 10.1016/j.cclet.2024.110098
20. [20]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(82)
HTML views(11)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142